ALAltimeter Capital Management, LP
Institutional investor · Portfolio as of Q3 2023
Top Holdings11 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
SNOWFLAKE INC-CLASS A | 15.4M | $2.4B | 44.7% | $244.54 | -37.53% | 13 qtrssince 2020-Q3 | Increased 65 |
META PLATFORMS INC-CLASS A | 2.4M | $721.9M | 13.7% | $156.60 | +90.37% | 20 qtrssince 2018-Q4 | Increased 69 |
UBER TECHNOLOGIES INC | 13.3M | $613.4M | 11.6% | $32.66 | +40.81% | 18 qtrssince 2019-Q2 | Unchanged 0 |
MICROSOFT CORP | 1.7M | $521.9M | 9.9% | $181.29 | +71.26% | 20 qtrssince 2018-Q4 | Increased 69 |
CONFLUENT INC | 16.6M | $491.9M | 9.3% | $33.14 | -10.66% | 10 qtrssince 2021-Q2 | Increased 65 |
NVIDIA CORP | 772,210 | $335.9M | 6.4% | $20.71 | +109.95% | 4 qtrssince 2022-Q4 | Increased 66 |
AMAZON.COM INC | 1.3M | $159.5M | 3.0% | $127.37 | -0.20% | 2 qtrssince 2023-Q2 | Increased 93 |
PDD HOLDINGS INC | 646,280 | $63.4M | 1.2% | $98.07 | 0.00% | 1 qtr | New 70 |
MERCADOLIBRE INC | 2,980 | $3.8M | 0.1% | $1,267.88 | 0.00% | 1 qtr | New 40 |
CONTROLADORA VUELA COMP DE A | 379,270 | $2.6M | 0.0% | $6.79 | +11.93% | 1 qtr | New 39 |
| 3.5M | $1.2M | 0.0% | — | — | 8 qtrssince 2021-Q4 | Unchanged 0 |
Altimeter Capital Management, LP manages $5.3B across 11 positions as of Q3 2023. Top holdings: SNOW (44.7%), META (13.7%), UBER (11.6%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.
Added 3 new positions, exited 3, increased 6. Top move: AMZN (INCREASED, conviction 93). Portfolio: $5.3B across 11 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer